7th December 2024
A closed workshop for regulatory authorities, “2024 Kobe COE Workshop for Biotherapeutics,” was held at Kobe University for three days from 3rd to 5th, December. Our company representative, Dr. Suzawa, gave a lecture and held a Q&A session on biopharmaceutical development trends and manufacturing processes for the attendees from each APEC region.
◇◇◇◇◇◇◇◇◇◇◇
1st March 2024
Research article has been published in Biotechnology Progress on 28th February 2024.
This study has been performed at Kyowa Kirin Co., Ltd., and reports on a case study for balancing between high antibody productivity and reduction of low molecular weight species in CHO cell culture of monoclonal antibody production process.
Tsuyoshi Yamaguchi et al., Catechins prevent monoclonal antibody fragmentation during production via fed-batch culture of Chinese hamster ovary cells, Biotechnology Progress, accepted 14th February 2024 / https://doi.org/10.1002/btpr.3447
◇◇◇◇◇◇◇◇◇◇◇
7th December 2023
Dr. Suzawa, President & CEO of BioStrad Lab, was invited as a lecturer for the APEC event “2023 Kobe CoE On-Site Workshop for Biotherapeutics” during 5th Dec. 2023 – 7th Dec. 2023 held at Kobe University.
◇◇◇◇◇◇◇◇◇◇◇
2nd December 2022
Dr. Suzawa, President & CEO of BioStrad Lab, was invited as a lecturer for the APEC event “2022 Kobe CoE Virtual Workshop for Biotherapeutics” during 30th Nov. 2022 – 2nd Dec. 2022.
◇◇◇◇◇◇◇◇◇◇◇
13th December 2021
Dr. Suzawa of BioStrad Lab was invited as a lecturer for Biosimilar Medicines Committee of Japanese Generic Medicines Association on 13th December 2021 to provide topics on “Overview of Biopharmaceuticals Development Trends and Outline of Process Development Including Biosimilar Products“.
◇◇◇◇◇◇◇◇◇◇◇
13th December 2021
Dr. Suzawa of BioStrad Lab was invited as a lecturer for the APEC event “2021 Kobe CoE Virtual Workshop for Biotherapeutics” during 1-3 Dec. 2021.
◇◇◇◇◇◇◇◇◇◇◇
4th December 2020
Dr. Suzawa of BioStrad Lab was invited as a lecturer for the APEC event “2020 Kobe CoE Virtual Workshop for Biotherapeutics” during 2-4 Dec. 2020. See the link for details.
◇◇◇◇◇◇◇◇◇◇◇
6th January 2020
BioStrad Lab LLC has been established (registered) as a new private company on 6th January 2020. We continue to support Biologcs CMC development and regulatory filings for the customers in and outside Japan.
◇◇◇◇◇◇◇◇◇◇◇
3rd – 5th December 2019
Dr. Suzawa of BioStrad Lab was invited as a lecturer for the APEC-granted pilot CoE program organized by Kobe University. During the 3 days workshop, reviewers and GMP inspectors in regulatory agencies coming from Asian countries and Brazil were joined in this lecture and practice courses on Biopharmaceutical process development and GMP inspection trainings.
◇◇◇◇◇◇◇◇◇◇◇
November 2019
BioStrad Lab has been entered into pertnership agreement with PointPath.Biz, K. K. Comprehensive collaboration in consultation services regarding biopharmaceutical development is possible. Please contact us for details.
◇◇◇◇◇◇◇◇◇◇◇
July 2019
Web site of BioStradLab has been released.
